Flash Therapeutics
Latest round
- Series A
Last raised
- Nov 2016
Total raised
- $5M
Investors
- 3
About Flash Therapeutics
Based in Massachusetts, US, Flash Therapeutics, LLC is a biotechnology company that focuses on developing an oral compound to prevent acute myeloid leukemia (AML) relapse. The company's team members have work experience in Merck, Bristol-Myers Squibb, Novartis, and Takeda, and have decades of drug-hunting experience. And the company team members have clinical experience when they worked in cancer research institutions and would access patient-derived tumor biology and ground-breaking research. The company has developed candidate oral drugs to prevent AML relapse, using novel findings linking Hematopoietic Cell Kinase (HCK) to AML. The HCK is a potential therapeutic target for leukemic cells. The company has identified five potential compounds for further testing. One is moving on to IND filing while the other four are going to begin animal toxicology testing.
Who invested in Flash Therapeutics
3 investors across 1 round
See all investors in Flash Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 1, 2016
Amount
$5M
Investors
Questions about Flash Therapeutics
Who invested in Flash Therapeutics?
Flash Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Flash Therapeutics raised?
Flash Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Flash Therapeutics last raise money?
Flash Therapeutics's most recent round on record is a Series A, in Nov 2016.
What does Flash Therapeutics do?
Based in Massachusetts, US, Flash Therapeutics, LLC is a biotechnology company that focuses on developing an oral compound to prevent acute myeloid leukemia (AML) relapse.
Where is Flash Therapeutics headquartered?
Flash Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Flash Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Flash Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Flash Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.